Financials & Filings

OTCQB: INTI
PRICE:
Stock Info

This section of the Inhibitor Therapeutics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Inhibitor Therapeutics assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

Beta(1.33)
Shares Outstanding370.4M
Average Volume (10 days)2.9K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.01)
Sales (TTM)$0.00
Book Value (MRQ)($0.01)
Cash Flow (TTM)($0.01)
Cash (MRQ)$0.01

Analyst Views

Current Mean RecommendationN/A
Strong Buy0
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Paul D'Sylva
(19,100)
Sell
Jan 19, 2010
Paul D'Sylva
12,000
Buy
May 29, 2009
Paul D'Sylva
510
Buy
May 15, 2009
Paul D'Sylva
2,800
Buy
May 14, 2009
Paul D'Sylva
23,934
Buy
May 5, 2009

Recent SEC Filings

Company Events
Aug 27, 2019
Company Events
Aug 20, 2019
Quarterly Financials
Aug 12, 2019
Company Events
Jul 17, 2019
Company Events
Jul 1, 2019
Get Important News and Updates by Email
* Required Fields